American Hospital Dubai to help build an AI billing platform, not just buy one

Most hospitals buy software after it is finished. American Hospital Dubai has chosen to help write it. The hospital has signed on as the inaugural Alpha Partner for RevOptix, an AI-powered revenue cycle and patient accounting platform from HEI Global Health, and it will shape the product while using it.

The announcement came on 26 October 2026. American Hospital Dubai (AHD) is a member of the Mayo Clinic Care Network. HEI is a healthcare technology and consulting company founded in 2005, and it has served revenue cycle clients in the Middle East since 2012. Brian Raggett of HEI and AHD Group CFO Rohit Gandhi marked the signing of the agreement.

How will it work?

HEI will deploy its Revenue Cycle Software Suite at AHD. The aim is to improve financial performance, streamline billing operations and make the patient's financial experience easier. The tools involved are artificial intelligence, workflow automation, predictive analytics and real-time operational intelligence.

The Alpha Partner role is the interesting part. AHD will work directly with HEI's product, engineering and executive teams to build and validate new features in a live hospital, not a test lab. In return, AHD gets early access to new technology. HEI gets feedback from people who actually run a busy revenue cycle.

The scope goes past installation. The two organizations plan to cover:

• Continuous product development and real-world validation
• AI-driven automation of revenue cycle workflows
• Joint customer success initiatives
• Research, thought leadership and best-practice sharing

Why does it matter?

Billing rarely makes headlines, but it decides how much money a hospital has to spend on care. Claims, denials, patient estimates and collections all drain staff time. Automation that spots problems early could free finance teams for more useful work.

Sherif Beshara, AHD's Group CEO, said the partnership lets the hospital contribute operational expertise while building solutions for the wider sector. Aaron Habben, HEI's CEO, called AHD an important part of the company's Middle East strategy and said real-world insight will sharpen its AI products. Both statements are promotional, and no performance figures have been released. So the claims of measurable results remain to be proven.

The context

The deal fits a clear regional pattern. Across the GCC, governments are pushing digital health as part of national agendas such as Saudi Vision 2030 and the UAE's health strategies. Most of that attention goes to electronic records, telemedicine and clinical AI. The financial back end has received less, even though insurers, mandatory coverage schemes and rising patient volumes make billing more complex every year.

Dubai in particular runs a heavily insured, private-sector-led market, where claim accuracy and speed matter a great deal. A provider with AHD's standing, including being the first hospital in the Middle East to earn Joint Commission International accreditation, gives the platform credibility with other regional operators.

The real test comes next. If RevOptix produces measurable gains in AHD's own operations, other hospital groups will take notice. If it does not, the Alpha Partner label will count for little. Either way, the co-development model is worth watching, because it treats a hospital as a builder of technology and not only a customer.